Cargando…
Atorvastatin does not ameliorate nephrogenic diabetes insipidus induced by lithium or potassium depletion in mice
Acquired forms of nephrogenic diabetes insipidus (NDI) include lithium (Li)‐induced and hypokalemia‐induced NDI. Both forms are associated with AQP2 downregulation and collecting duct (CD) cellular remodeling. Statins are cholesterol‐lowering drugs appearing to increase AQP2 membrane‐translocation a...
Autores principales: | Thomsen, Maria L., Grønkjær, Camilla, Iervolino, Anna, Rej, Soham, Trepiccione, Francesco, Christensen, Birgitte M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8582289/ https://www.ncbi.nlm.nih.gov/pubmed/34762363 http://dx.doi.org/10.14814/phy2.15111 |
Ejemplares similares
-
Atorvastatin in the treatment of Lithium-induced nephrogenic diabetes insipidus: the protocol of a randomized controlled trial
por: Fotso Soh, Jocelyn, et al.
Publicado: (2018) -
Absence of PKC-Alpha Attenuates Lithium-Induced Nephrogenic Diabetes Insipidus
por: Sim, Jae H., et al.
Publicado: (2014) -
Tamoxifen Decreases Lithium-Induced Natriuresis in Rats With Nephrogenic Diabetes Insipidus
por: Tingskov, Stine Julie, et al.
Publicado: (2018) -
A Rare Case of Lithium-induced Partial Nephrogenic Diabetes Insipidus
por: Rauf, Abdul, et al.
Publicado: (2020) -
SUN-283 Lithium Induced Partial Nephrogenic Insipidus: An Unusual Presentation
por: Akagi, Roberto Kenji Mitsui, et al.
Publicado: (2020)